03/25/2025
3:46 PM | Climb Bio, Inc. (Filer)
Climb Bio (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/25/2025
3:35 PM | Climb Bio, Inc. (Filer)
Climb Bio (Filer)
| Form 424B5 | |
03/20/2025
4:21 PM | Climb Bio, Inc. (Issuer)
Climb Bio (Issuer)
Pimblett Emily (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2025
2:56 PM | BML Investment Partners, L.P. (Filed by)
Climb Bio, Inc. (Subject)
Climb Bio (Subject)
| Form SCHEDULE 13G/A | |
01/15/2025
3:15 PM | Climb Bio, Inc. (Issuer)
Climb Bio (Issuer)
Kaplan Brett (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/15/2025
3:15 PM | Climb Bio, Inc. (Issuer)
Climb Bio (Issuer)
Pimblett Emily (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/15/2025
3:15 PM | Brennan Aoife (Reporting)
Climb Bio, Inc. (Issuer)
Climb Bio (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/10/2025
7:08 AM | Climb Bio, Inc. (Filer)
Climb Bio (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/20/2024
3:15 PM | Climb Bio, Inc. (Issuer)
Climb Bio (Issuer)
Pimblett Emily (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/24/2024
11:15 PM | Climb Bio, Inc. (Filer)
Climb Bio (Filer)
| Form EFFECT | |
11/14/2024
8:29 AM | Climb Bio, Inc. (Subject)
Climb Bio (Subject)
Deep Track Capital, LP (Filed by)
| Form SC 13G/A | |
Get the Latest News and Ratings for CLYM and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Climb Bio and its competitors with MarketBeat's FREE daily newsletter. |
11/12/2024
3:51 PM | Climb Bio, Inc. (Filer)
Climb Bio (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
10/15/2024
6:08 AM | Climb Bio, Inc. (Filer)
Climb Bio (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/20/2024
8:53 PM | Eliem Therapeutics, Inc. (Issuer)
Climb Bio (Issuer)
Pimblett Emily (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/27/2024
4:21 PM | Eliem Therapeutics, Inc. (Filer)
Climb Bio (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/26/2024
4:47 PM | Eliem Therapeutics, Inc. (Issuer)
Climb Bio (Issuer)
Kaplan Brett (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/26/2024
4:40 PM | Eliem Therapeutics, Inc. (Issuer)
Climb Bio (Issuer)
Kaplan Brett (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/26/2024
6:07 AM | Eliem Therapeutics, Inc. (Filer)
Climb Bio (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/16/2024
3:23 PM | AI ETI LLC (Filed by)
Eliem Therapeutics, Inc. (Subject)
Climb Bio (Subject)
| Form SC 13D/A | |
08/14/2024
5:06 AM | Eliem Therapeutics, Inc. (Filer)
Climb Bio (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/14/2024
5:10 AM | Eliem Therapeutics, Inc. (Filer)
Climb Bio (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/23/2024
11:15 PM | Eliem Therapeutics, Inc. (Filer)
Climb Bio (Filer)
| Form EFFECT | |
07/23/2024
4:04 PM | Eliem Therapeutics, Inc. (Issuer)
Climb Bio (Issuer)
Morisset Valerie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/23/2024
3:31 PM | Eliem Therapeutics, Inc. (Filer)
Climb Bio (Filer)
| Form 424B3 | |
07/19/2024
10:12 AM | Eliem Therapeutics, Inc. (Issuer)
Climb Bio (Issuer)
Morisset Valerie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/17/2024
5:11 PM | Eliem Therapeutics, Inc. (Issuer)
Climb Bio (Issuer)
Morisset Valerie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/16/2024
5:14 PM | Eliem Therapeutics, Inc. (Issuer)
Climb Bio (Issuer)
Morisset Valerie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/11/2024
7:45 PM | Eliem Therapeutics, Inc. (Issuer)
Climb Bio (Issuer)
Morisset Valerie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/09/2024
3:46 PM | Eliem Therapeutics, Inc. (Issuer)
Climb Bio (Issuer)
Morisset Valerie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2024
1:42 PM | Eliem Therapeutics, Inc. (Issuer)
Climb Bio (Issuer)
Morisset Valerie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2024
3:38 PM | Eliem Therapeutics, Inc. (Filer)
Climb Bio (Filer)
| Form D
Notice of Exempt Offering of Securities | |
07/02/2024
3:39 PM | Eliem Therapeutics, Inc. (Filer)
Climb Bio (Filer)
| Form D
Notice of Exempt Offering of Securities | |
07/02/2024
3:01 PM | Deep Track Capital, LP (Filed by)
Eliem Therapeutics, Inc. (Subject)
Climb Bio (Subject)
| Form SC 13G | |
07/01/2024
8:28 PM | Eliem Therapeutics, Inc. (Subject)
Climb Bio (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SC 13D/A | |
07/01/2024
8:29 PM | Eliem Therapeutics, Inc. (Issuer)
Climb Bio (Issuer)
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA Capital Nexus Fund II, L.P. (Reporting)
RA Capital Nexus Fund III, L.P. (Reporting)
RA Capital Nexus Fund, L.P. (Reporting)
Shah Rajeev M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/28/2024
5:09 PM | Eliem Therapeutics, Inc. (Issuer)
Climb Bio (Issuer)
Levin Andrew David (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/28/2024
5:14 PM | Eliem Therapeutics, Inc. (Issuer)
Climb Bio (Issuer)
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA Capital Nexus Fund II, L.P. (Reporting)
RA Capital Nexus Fund, L.P. (Reporting)
Shah Rajeev M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/28/2024
4:23 PM | Dunn Judith (Reporting)
Eliem Therapeutics, Inc. (Issuer)
Climb Bio (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/28/2024
4:26 PM | Eliem Therapeutics, Inc. (Issuer)
Climb Bio (Issuer)
Rosenberg Adam Joseph (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/28/2024
4:09 PM | Eliem Therapeutics, Inc. (Issuer)
Climb Bio (Issuer)
Ratcliffe Liam (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/28/2024
4:13 PM | Eliem Therapeutics, Inc. (Issuer)
Climb Bio (Issuer)
Tate Simon (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Here’s how you could profit from Elon’s NVIDIA partnership (Ad) Elon Musk recently offered NVIDIA $1 billion...
To buy a cluster of their cutting-edge GB200 AI chips.
Why?
Because Elon is quietly building the most powerful AI supercomputer on the planet.
It's called "Project Colossus"... Don't know where to start investing in AI? Check out my latest investor briefing. |
06/27/2024
6:00 PM | Brennan Aoife (Reporting)
Eliem Therapeutics, Inc. (Issuer)
Climb Bio (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
06/27/2024
6:01 PM | Eliem Therapeutics, Inc. (Issuer)
Climb Bio (Issuer)
Thomas Stephen Basil (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
06/27/2024
6:03 PM | Eliem Therapeutics, Inc. (Issuer)
Climb Bio (Issuer)
Thomas Stephen Basil (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2024
6:05 PM | Brennan Aoife (Reporting)
Eliem Therapeutics, Inc. (Issuer)
Climb Bio (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2024
3:22 PM | Eliem Therapeutics, Inc. (Filer)
Climb Bio (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/26/2024
3:23 PM | Eliem Therapeutics, Inc. (Filer)
Climb Bio (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/21/2024
1:57 PM | Eliem Therapeutics, Inc. (Issuer)
Climb Bio (Issuer)
Pimblett Emily (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2024
3:41 PM | Eliem Therapeutics, Inc. (Filer)
Climb Bio (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/12/2024
3:42 PM | Eliem Therapeutics, Inc. (Filer)
Climb Bio (Filer)
| Form DEFA14A | |
06/04/2024
7:00 AM | Eliem Therapeutics, Inc. (Filer)
Climb Bio (Filer)
| Form DEFM14A | |
06/04/2024
7:05 AM | Eliem Therapeutics, Inc. (Filer)
Climb Bio (Filer)
| Form ARS | |
05/15/2024
5:19 AM | Eliem Therapeutics, Inc. (Filer)
Climb Bio (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/07/2024
5:01 PM | Affinity Asset Advisors, LLC (Filed by)
Eliem Therapeutics, Inc. (Subject)
Climb Bio (Subject)
| Form SC 13G | |
04/12/2024
5:52 PM | Eliem Therapeutics, Inc. (Subject)
Climb Bio (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SC 13D/A | |
04/11/2024
7:01 AM | Eliem Therapeutics, Inc. (Filer)
Climb Bio (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/11/2024
7:10 AM | Eliem Therapeutics, Inc. (Filer)
Climb Bio (Filer)
| Form DEFA14A | |
04/08/2024
4:33 PM | Eliem Therapeutics, Inc. (Issuer)
Climb Bio (Issuer)
Morisset Valerie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
